Atlas Trials

Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis

Clinical trial NCT02722447 · UNKNOWN

Trial details

NCT number
NCT02722447
Sponsor
Walter Ageno
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Deep Vein Thrombosis
Start date
2017-01-01
Primary completion
2019-06-01
Enrollment
1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.